CEO: Michael Kleine
Headquarters: Santa Clara, CA
Investment Date: June 2016
APO Financing: $10,000,000 (Acquired in July 2017 for $34 Million by Sientra, Inc. )
Trading Venue: Acquired
Founded in 2006, Miramar Labs is a global medical device company dedicated to bringing the next generation energy modality to the field of dermatology. Supported by rigorous clinical research, Miramar Labs is focused on addressing aesthetic medical conditions for which there are significant unmet clinical needs. The company’s first priority is advancing aesthetic treatments using its proprietary miraWave™ technology platform. miraWave harnesses the unique benefits of microwave energy to treat dermatologic conditions such as axillary sweat and hair of all colors.